Taking the stock of granule cargo: Platelet releasate proteomics

Platelets

Volumn 28, Issue 2, 2017, Pages 119-128

  Pagel, Oliver ^a   Walter, Elena ^b   Jurk, Kerstin ^b   Zahedi, René P ^a  

^a LEIBNIZ INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN ISAS E V   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

granule cargo; LC MS MS based proteomics; platelet releasate; sample preparation

Indexed keywords

PROTEOME;

BLOOD CLOTTING; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEOMICS; REVIEW; THROMBOCYTE; THROMBOCYTE AGGREGATION; ANIMAL; CELL GRANULE; METABOLISM; PROCEDURES;

ANIMALS; BLOOD PLATELETS; CYTOPLASMIC GRANULES; HUMANS; PROTEOME; PROTEOMICS;

EID: 85014936945     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537104.2016.1254762     Document Type: Review

References (105)

1. Blair P, Flaumenhaft R., Platelet alpha-granules:basic biology and clinical correlates. Blood Rev 2009;23(4):177–189.
2. Golebiewska EM, Poole AW., Platelet secretion:from haemostasis to wound healing and beyond. Blood Rev 2015;29(3):153–162.
3. Kuijpers MJ, de Witt S, Nergiz-Unal R, van Kruchten R, Korporaal SJ, Verhamme P, Febbraio M, Tjwa M, Voshol PJ, Hoylaerts MF, et al. Supporting roles of platelet thrombospondin-1 and CD36 in thrombus formation on collagen. Arterioscler Thromb Vasc Biol 2014;34(6):1187–1192.
4. Bambace NM, Holmes CE., The platelet contribution to cancer progression. J Thromb Haemost 2011;9(2):237–249.
5. Villeneuve J, Block A, Le Bousse-Kerdiles MC, Lepreux S, Nurden P, Ripoche J, Nurden AT., Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes:a novel organization for these secreted proteins. Exp Hematol 2009;37(7):849–856.
6. Mastenbroek TG, Feijge MA, Kremers RM, van den Bosch MT, Swieringa F, De Groef L, Moons L, Bennett C, Ghevaert C, Johnson JL, et al. Platelet-associated matrix metalloproteinases regulate thrombus formation and exert local collagenolytic activity. Arterioscler Thromb Vasc Biol 2015;35(12):2554–2561.
7. Schmaier AH, Smith PM, Purdon AD, White JG, Colman RW., High molecular weight kininogen:localization in the unstimulated and activated platelet and activation by a platelet calpain(s). Blood 1986;67(1):119–130.
8. Erickson LA, Ginsberg MH, Loskutoff DJ., Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest 1984;74(4):1465–1472.
9. D’Angelo A, Lockhart MS, D’Angelo SV, Taylor FB, Jr. Protein S is a cofactor for activated protein C neutralization of an inhibitor of plasminogen activation released from platelets. Blood 1987;69(1):231–237.
10. Gleissner CA, von Hundelshausen P, Ley K., Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol 2008;28(11):1920–1927.
11. Ivanciu L, Stalker TJ., Spatiotemporal regulation of coagulation and platelet activation during the hemostatic response in vivo. J Thromb Haemost 2015;13(11):1949–1959.
12. Sakurai Y, Fitch-Tewfik JL, Qiu Y, Ahn B, Myers DR, Tran R, Fay ME, Ding L, Spearman PW, Michelson AD, et al. Platelet geometry sensing spatially regulates alpha-granule secretion to enable matrix self-deposition. Blood 2015;126(4):531–538.
13. Maynard DM, Heijnen HF, Horne MK, White JG, Gahl WA., Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 2007;5(9):1945–1955.
14. Suzuki H, Murasaki K, Kodama K, Takayama H., Intracellular localization of glycoprotein VI in human platelets and its surface expression upon activation. Br J Haematol 2003;121(6):904–912.
15. Furie B, Furie BC, Flaumenhaft R., A journey with platelet P-selectin:the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 2001;86(1):214–221.
16. Gardiner EE, Al-Tamimi M, Andrews RK, Berndt MC., Platelet receptor shedding. Methods Mol Biol 2012;788:321–339.
17. Sehgal S, Storrie B., Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J Thromb Haemost 2007;5(10):2009–2016.
18. Kamykowski J, Carlton P, Sehgal S, Storrie B., Quantitative immunofluorescence mapping reveals little functional coclustering of proteins within platelet alpha-granules. Blood 2011;118(5):1370–1373.
19. Ma L, Perini R, McKnight W, Dicay M, Klein A, Hollenberg MD, Wallace JL., Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci USA 2005;102(1):216–220.
20. Italiano JE, Jr., Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, Ryeom S, Folkman J, Klement GL., Angiogenesis is regulated by a novel mechanism:pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008;111(3):1227–1233.
21. Chatterjee M, Huang Z, Zhang W, Jiang L, Hultenby K, Zhu L, Hu H, Nilsson GP, Li N., Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli. Blood 2011;117(14):3907–3911.
22. Battinelli EM, Markens BA, Italiano JE, Jr. Release of angiogenesis regulatory proteins from platelet alpha granules:modulation of physiologic and pathologic angiogenesis. Blood 2011;118(5):1359–1369.
23. Peters CG, Michelson AD, Flaumenhaft R., Granule exocytosis is required for platelet spreading:differential sorting of alpha-granules expressing VAMP-7. Blood 2012;120(1):199–206.
24. Jonnalagadda D, Izu LT, Whiteheart SW., Platelet secretion is kinetically heterogeneous in an agonist-responsive manner. Blood 2012;120(26):5209–5216.
25. Jurk K, Schulz AS, Kehrel BE, Rapple D, Schulze H, Mobest D, Friedrich WW, Omran H, Deak E, Henschler R, et al. Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3. Thromb Haemost 2010;103(5):1053–1064.
26. Velez P, Izquierdo I, Rosa I, Garcia A., A 2D-DIGE-based proteomic analysis reveals differences in the platelet releasate composition when comparing thrombin and collagen stimulations. Sci Rep 2015;5:8198.
27. van Holten TC, Bleijerveld OB, Wijten P, de Groot PG, Heck AJ, Barendrecht AD, Merkx TH, Scholten A, Roest M., Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets. Cardiovasc Res 2014;103(1):140–146.
28. Kowalska MA, Rauova L, Poncz M., Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis. Thromb Res 2010;125(4):292–296.
29. Clemetson KJ., The role of platelets in defence against pathogens. Hamostaseologie 2011;31(4):264–268.
30. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp BK, Piccinini AM, Paludan SR, Kowalska MA, et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 2009;15(1):97–103.
31. Chatterjee M, Gawaz M., Platelet-derived CXCL12 (SDF-1alpha):basic mechanisms and clinical implications. J Thromb Haemost 2013;11(11):1954–1967.
32. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD., Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000;97(25):13835–13840.
33. Hrachovinova I, Cambien B, Hafezi-Moghadam A, Kappelmayer J, Camphausen RT, Widom A, Xia L, Kazazian HH, Jr., Schaub RG, McEver RP, et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 2003;9(8):1020–1025.
34. Ridker PM, Buring JE, Rifai N., Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001;103(4):491–495.
35. Pabinger I, Thaler J, Ay C., Biomarkers for prediction of venous thromboembolism in cancer. Blood 2013;122(12):2011–2018.
36. Mammadova-Bach E, Mangin P, Lanza F, Gachet C., Platelets in cancer. From basic research to therapeutic implications. Hamostaseologie 2015;35(4):325–336.
37. Yeaman MR., Platelets:at the nexus of antimicrobial defence. Nat Rev Microbiol 2014;12(6):426–437.
38. Horn M, Bertling A, Brodde MF, Muller A, Roth J, Van Aken H, Jurk K, Heilmann C, Peters G, Kehrel BE., Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa. J Thromb Haemost 2012;10(4):647–661.
39. Gunay-Aygun M, Falik-Zaccai TC, Vilboux T, Zivony-Elboum Y, Gumruk F, Cetin M, Khayat M, Boerkoel CF, Kfir N, Huang Y, et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet alpha-granules. Nat Genet 2011;43(8):732–734.
40. Deppermann C, Cherpokova D, Nurden P, Schulz JN, Thielmann I, Kraft P, Vogtle T, Kleinschnitz C, Dutting S, Krohne G, et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J, Clin Invest 2013.
41. Essex DW, Li M., Protein disulphide isomerase mediates platelet aggregation and secretion. Br J Haematol 1999;104(3):448–454.
42. Lahav J, Jurk K, Hess O, Barnes MJ, Farndale RW, Luboshitz J, Kehrel BE., Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood 2002;100(7):2472–2478.
43. Jurk K, Lahav J, H VANA, Brodde MF, Nofer JR, Kehrel BE., Extracellular protein disulfide isomerase regulates feedback activation of platelet thrombin generation via modulation of coagulation factor binding. J Thromb Haemost 2011;9(11):2278–2290.
44. Thon JN, Peters CG, Machlus KR, Aslam R, Rowley J, Macleod H, Devine MT, Fuchs TA, Weyrich AS, Semple JW, et al. T granules in human platelets function in TLR9 organization and signaling. J Cell Biol 2012;198(4):561–574.
45. van Nispen Tot Pannerden, HE, van Dijk, SM, Du V, Heijnen, HF. Platelet protein disulfide isomerase is localized in the dense tubular system and does not become surface expressed after activation. Blood 2009;114(21):4738–4740.
46. Crescente M, Pluthero FG, Li L, Lo RW, Walsh TG, Louriero S, Ali MS, Vaiyapuri S, Schenk MP, Holbrook LM, et al. Intracellular trafficking, localization, and mobilization of platelet-borne thiol isomerases. Arterioscler Thromb Vasc Biol 2016.
47. Mauler M, Bode C, Duerschmied D., Platelet serotonin modulates immune functions. Hamostaseologie 2016;36(1):11–16.
48. Loyer X, Vion AC, Tedgui A, Boulanger CM., Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 2014;114(2):345–353.
49. Aatonen M, Gronholm M, Siljander PR., Platelet-derived microvesicles:multitalented participants in intercellular communication. Semin Thromb Hemost 2012;38(1):102–113.
50. Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, Lindemann S, Yost CC, Rubner FJ, Albertine KH, Swoboda KJ, et al. Escaping the nuclear confines:signal-dependent pre-mRNA splicing in a nucleate platelets. Cell 2005;122(3):379–391.
51. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS., Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001;154(3):485–490.
52. Hottz ED, Lopes JF, Freitas C, Valls-de-Souza R, Oliveira MF, Bozza MT, Da Poian AT, Weyrich AS, Zimmerman GA, Bozza FA, et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood 2013;122(20):3405–3414.
53. Berndt MC, Karunakaran D, Gardiner EE, Andrews RK., Programmed autologous cleavage of platelet receptors. J Thromb Haemost 2007;5 Suppl 1:212–219.
54. Blobel CP., ADAMs:key components in EGFR signalling and development. Nat Rev Mol Cell Biol 2005;6(1):32–43.
55. Seals DF, Courtneidge SA., The ADAMs family of metalloproteases:multidomain proteins with multiple functions. Genes Dev 2003;17(1):7–30.
56. Rabie T, Strehl A, Ludwig A, Nieswandt B., Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 2005;280(15):14462–14468.
57. Bergmeier W, Piffath CL, Cheng G, Dole VS, Zhang Y, von Andrian UH, Wagner DD., Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res 2004;95(7):677–683.
58. Garton KJ, Gough PJ, Philalay J, Wille PT, Blobel CP, Whitehead RH, Dempsey PJ, Raines EW., Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J Biol Chem 2003;278(39):37459–37464.
59. Zhu L, Bergmeier W, Wu J, Jiang H, Stalker TJ, Cieslak M, Fan R, Boumsell L, Kumanogoh A, Kikutani H, et al. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci USA 2007;104(5):1621–1626.
60. Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, Maguire PB., Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004;103(6):2096–2104.
61. Washburn MP, Wolters D, Yates JR, 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001;19(3):242–247.
62. Seizer P, Fuchs C, Ungern-Sternberg, SNIv, Heinzmann D, Langer H, Gawaz M, May AE, Geisler T., Platelet-bound cyclophilin A in patients with stable coronary artery disease and acute myocardial infarction. Platelets 2016;27(2):155–158.
63. Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF., The platelet microparticle proteome. J Proteome Res 2005;4(5):1516–1521.
64. Hernandez-Ruiz L, Valverde F, Jimenez-Nunez MD, Ocana E, Saez-Benito A, Rodriguez-Martorell J, Bohorquez JC, Serrano A, Ruiz FA., Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J Proteome Res 2007;6(11):4449–4457.
65. Maynard DM, Heijnen HF, Gahl WA, Gunay-Aygun M., The alpha-granule proteome:novel proteins in normal and ghost granules in gray platelet syndrome. J Thromb Haemost 2010;8(8):1786–1796.
66. Coppinger JA, O’Connor R, Wynne K, Flanagan M, Sullivan M, Maguire PB, Fitzgerald DJ, Cagney G., Moderation of the platelet releasate response by aspirin. Blood 2007;109(11):4786–4792.
67. Whiteheart SW., Platelet granules:surprise packages. Blood 2011;118(5):1190–1191.
68. Dean WL, Lee MJ, Cummins TD, Schultz DJ, Powell DW., Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost 2009;102(4):711–718.
69. Shai E, Rosa I, Parguina AF, Motahedeh S, Varon D, Garcia A., Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J Proteomics 2012;76 Spec No.:287–296.
70. Wijten P, van Holten T, Woo LL, Bleijerveld OB, Roest M, Heck AJ, Scholten A., High precision platelet releasate definition by quantitative reversed protein profiling–brief report. Arterioscler Thromb Vasc Biol 2013;33(7):1635–1638.
71. Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Geiger J, Sickmann A, Zahedi RP., The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012;120(15):e73–e82.
72. Fong KP, Barry C, Tran AN, Traxler EA, Wannemacher KM, Tang HY, Speicher KD, Blair IA, Speicher DW, Grosser T, et al. Deciphering the human platelet sheddome. Blood 2011;117(1):e15–e26.
73. Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, Nurden P, Rao AK, Schmaier AH, Watson SP, et al. Recommendations for the Standardization of Light Transmission Aggregometry:a Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH. J Thromb Haemost 2013.
74. Schweigel H, Geiger J, Beck F, Buhs S, Gerull H, Walter U, Sickmann A, Nollau P., Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling. Proteomics 2013;13(6):1016–1027.
75. Beck, FG J, Gambaryan S, Veit J, Vaudel M, Nollau P, Kohlbacher O, Martens L, Walter U, Sickmann A, Zahedi RP., Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways. Blood 2014;123(5):e1–e10.
76. Piersma SR, Broxterman HJ, Kapci M, de Haas RR, Hoekman K, Verheul HM, Jimenez CR., Proteomics of the TRAP-induced platelet releasate. J Proteomics 2009;72(1):91–109.
77. O’Connor R, Cryan LM, Wynne K, de Stefani A, Fitzgerald D, O’Brien C, Cagney G., Proteomics strategy for identifying candidate bioactive proteins in complex mixtures:application to the platelet releasate. J Biomed Biotechnol 2010;2010:107859.
78. Garcia A, Senis YA, Antrobus R, Hughes CE, Dwek RA, Watson SP, Zitzmann N., A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets:involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 2006;6(19):5332–5343.
79. Cini C, Yip C, Attard C, Karlaftis V, Monagle P, Linden M, Ignjatovic V., Differences in the resting platelet proteome and platelet releasate between healthy children and adults. J Proteomics 2015;123:78–88.
80. Della Corte A, Maugeri N, Pampuch A, Cerletti C, de Gaetano G, Rotilio D., Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretome. Platelets 2008;19(1):43–50.
81. Di Michele M, Thys C, Waelkens E, Overbergh L, D’Hertog W, Mathieu C, De Vos R, Peerlinck K, Van Geet C, Freson K., An integrated proteomics and genomics analysis to unravel a heterogeneous platelet secretion defect. J Proteomics 2011;74(6):902–913.
82. Zybailov B, Mosley AL, Sardiu ME, Coleman MK, Florens L, Washburn MP., Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res 2006;5(9):2339–2347.
83. Wang W, Zhou H, Lin H, Roy S, Shaler TA, Hill LR, Norton S, Kumar P, Anderle M, Becker CH., Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal Chem 2003;75(18):4818–4826.
84. Sandin M, Chawade A, Levander F., Is label-free LC-MS/MS ready for biomarker discovery? Proteomics Clin Appl 2015; 9 (3–4):289–294.
85. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004;3(12):1154–1569.
86. Treitz C, Cassidy L, Hockendorf A, Leippe M, Tholey A., Quantitative proteome analysis of caenorhabditis elegans upon exposure to nematicidal Bacillus thuringiensis. J Proteomics 2015;113:337–350.
87. Thompson A, Schafer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, Neumann T, Johnstone R, Mohammed AK, Hamon C., Tandem mass tags:a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem 2003;75(8):1895–1904.
88. Erickson BK, Jedrychowski MP, McAlister GC, Everley RA, Kunz R, Gygi SP., Evaluating multiplexed quantitative phosphopeptide analysis on a hybrid quadrupole mass filter/linear ion trap/orbitrap mass spectrometer. Anal Chem 2015;87(2):1241–1249.
89. Westbrook JA, Noirel J, Brown JE, Wright PC, Evans CA., Quantitation with chemical tagging reagents in biomarker studies. Proteomics Clin Appl 2015; 9 (3–4):295–300.
90. Chambers AG, Percy AJ, Yang J, Borchers CH., Multiple Reaction Monitoring Enables Precise Quantification of 97 Proteins in Dried Blood Spots. Mol Cell Proteomics 2015;14(11):3094–3104.
91. Bourmaud A, Gallien S, Domon B., Parallel reaction monitoring using quadrupole-Orbitrap mass spectrometer:principle and applications. Proteomics 2016; 16 (15–16):2146–2159.
92. Parker CE, Borchers CH., Mass spectrometry based biomarker discovery, verification, and validation–quality assurance and control of protein biomarker assays. Mol Oncol 2014;8(4):840–858.
93. Carr SA, Abbatiello SE, Ackermann BL, Borchers C, Domon B, Deutsch EW, Grant RP, Hoofnagle AN, Huttenhain R, Koomen JM, et al. Targeted peptide measurements in biology and medicine:best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol Cell Proteomics 2014;13(3):907–917.
94. Domon B, Gallien S., Recent advances in targeted proteomics for clinical applications. Proteomics Clin Appl 2015; 9 (3–4):423–431.
95. Alpert AJ., Electrostatic repulsion hydrophilic interaction chromatography for isocratic separation of charged solutes and selective isolation of phosphopeptides. Anal Chem 2008;80(1):62–76.
96. Loroch S, Zahedi RP, Sickmann A., Highly sensitive phosphoproteomics by tailoring solid-phase extraction to electrostatic repulsion-hydrophilic interaction chromatography. Anal Chem 2015;87(3):1596–1604.
97. Yu Z, Han G, Sun S, Jiang X, Chen R, Wang F, Wu R, Ye M, Zou H., Preparation of monodisperse immobilized Ti(4+) affinity chromatography microspheres for specific enrichment of phosphopeptides. Anal Chim Acta 2009;636(1):34–41.
98. de Graaf EL, Giansanti P, Altelaar AF, Heck AJ., Single-step enrichment by Ti4+-IMAC and label-free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution. Mol Cell Proteomics 2014;13(9):2426–2434.
99. Engholm-Keller K, Birck P, Storling J, Pociot F, Mandrup-Poulsen T, Larsen MR. TiSH–a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2, SIMAC, and HILIC. J Proteomics 2012;75(18):5749–5761.
100. Gauci S, Helbig AO, Slijper M, Krijgsveld J, Heck AJ, Mohammed S., Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem 2009;81(11):4493–4501.
101. Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J., Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol 2003;21(5):566–569.
102. Venne AS, Vögtle FN, Meisinger C, Sickmann A, Zahedi RP., Novel highly sensitive, specific, and straightforward strategy for comprehensive N-terminal proteomics reveals unknown substrates of the mitochondrial peptidase Icp55. J Proteome Res 2013;12(9):3823–3830.
103. Kleifeld O, Doucet A, Auf dem Keller U, Prudova A, Schilling O, Kainthan RK, Starr AE, Foster LJ, Kizhakkedathu JN, Overall CM. Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat Biotechnol 2010;28(3):281–288.
104. Pagel O, Loroch S, Sickmann A, Zahedi RP., Current strategies and findings in clinically relevant post-translational modification-specific proteomics. Expert Rev Proteomics 2015;12(3):235–253.
105. Coman C, Solari FA, Hentschel A, Sickmann A, Zahedi RP, Ahrends R., Simultaneous metabolite, protein, lipid extraction (SIMPLEX):a combinatorial multimolecular omics approach for systems biology. Mol Cell Proteomics 2016;15(4):1453–1466.